CN Patent

CN112512506A — 肾上腺素喷雾制剂

Assigned to Hickma Pharmaceutical Usa Co ltd · Expires 2021-03-16 · 5y expired

What this patent protects

本发明涉及肾上腺素喷雾制剂。本发明还涉及通过向需要过敏反应治疗的受试者给药肾上腺素喷雾制剂来治疗过敏反应的方法。

USPTO Abstract

本发明涉及肾上腺素喷雾制剂。本发明还涉及通过向需要过敏反应治疗的受试者给药肾上腺素喷雾制剂来治疗过敏反应的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN112512506A
Jurisdiction
CN
Classification
—
Expires
2021-03-16
Drug substance claim
No
Drug product claim
No
Assignee
Hickma Pharmaceutical Usa Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.